Applying specific thermal doses via PBNP-PTT offers a potential strategy for recovering immune surveillance of both MYCN-non-amplified and, to a lower extent, MYCN-amplified neuroblastoma by upregulating HLA-ABC and/or HLA-DR. This evidence concerns the gene MYCN and neuroblastoma.